CHAPTER 9: HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET, BY REGION
9.1 Overview
9.1.1 Market size and forecast
9.2 North America
9.2.1 Key trends and opportunities
9.2.2 North America Market size and forecast, by By Product
9.2.3 North America Market size and forecast, by By Test Type
9.2.4 North America Market size and forecast, by By Application
9.2.5 North America Market size and forecast, by By Infection Type
9.2.6 North America Market size and forecast, by End User
9.2.7 North America Market size and forecast, by country
9.2.7.1 U.S.
9.2.7.1.1 Market size and forecast, by By Product
9.2.7.1.2 Market size and forecast, by By Test Type
9.2.7.1.3 Market size and forecast, by By Application
9.2.7.1.4 Market size and forecast, by By Infection Type
9.2.7.1.5 Market size and forecast, by End User
9.2.7.2 Canada
9.2.7.2.1 Market size and forecast, by By Product
9.2.7.2.2 Market size and forecast, by By Test Type
9.2.7.2.3 Market size and forecast, by By Application
9.2.7.2.4 Market size and forecast, by By Infection Type
9.2.7.2.5 Market size and forecast, by End User
9.2.7.3 Mexico
9.2.7.3.1 Market size and forecast, by By Product
9.2.7.3.2 Market size and forecast, by By Test Type
9.2.7.3.3 Market size and forecast, by By Application
9.2.7.3.4 Market size and forecast, by By Infection Type
9.2.7.3.5 Market size and forecast, by End User
9.3 Europe
9.3.1 Key trends and opportunities
9.3.2 Europe Market size and forecast, by By Product
9.3.3 Europe Market size and forecast, by By Test Type
9.3.4 Europe Market size and forecast, by By Application
9.3.5 Europe Market size and forecast, by By Infection Type
9.3.6 Europe Market size and forecast, by End User
9.3.7 Europe Market size and forecast, by country
9.3.7.1 Germany
9.3.7.1.1 Market size and forecast, by By Product
9.3.7.1.2 Market size and forecast, by By Test Type
9.3.7.1.3 Market size and forecast, by By Application
9.3.7.1.4 Market size and forecast, by By Infection Type
9.3.7.1.5 Market size and forecast, by End User
9.3.7.2 France
9.3.7.2.1 Market size and forecast, by By Product
9.3.7.2.2 Market size and forecast, by By Test Type
9.3.7.2.3 Market size and forecast, by By Application
9.3.7.2.4 Market size and forecast, by By Infection Type
9.3.7.2.5 Market size and forecast, by End User
9.3.7.3 U.K.
9.3.7.3.1 Market size and forecast, by By Product
9.3.7.3.2 Market size and forecast, by By Test Type
9.3.7.3.3 Market size and forecast, by By Application
9.3.7.3.4 Market size and forecast, by By Infection Type
9.3.7.3.5 Market size and forecast, by End User
9.3.7.4 Italy
9.3.7.4.1 Market size and forecast, by By Product
9.3.7.4.2 Market size and forecast, by By Test Type
9.3.7.4.3 Market size and forecast, by By Application
9.3.7.4.4 Market size and forecast, by By Infection Type
9.3.7.4.5 Market size and forecast, by End User
9.3.7.5 Spain
9.3.7.5.1 Market size and forecast, by By Product
9.3.7.5.2 Market size and forecast, by By Test Type
9.3.7.5.3 Market size and forecast, by By Application
9.3.7.5.4 Market size and forecast, by By Infection Type
9.3.7.5.5 Market size and forecast, by End User
9.3.7.6 Rest of Europe
9.3.7.6.1 Market size and forecast, by By Product
9.3.7.6.2 Market size and forecast, by By Test Type
9.3.7.6.3 Market size and forecast, by By Application
9.3.7.6.4 Market size and forecast, by By Infection Type
9.3.7.6.5 Market size and forecast, by End User
9.4 Asia-Pacific
9.4.1 Key trends and opportunities
9.4.2 Asia-Pacific Market size and forecast, by By Product
9.4.3 Asia-Pacific Market size and forecast, by By Test Type
9.4.4 Asia-Pacific Market size and forecast, by By Application
9.4.5 Asia-Pacific Market size and forecast, by By Infection Type
9.4.6 Asia-Pacific Market size and forecast, by End User
9.4.7 Asia-Pacific Market size and forecast, by country
9.4.7.1 Japan
9.4.7.1.1 Market size and forecast, by By Product
9.4.7.1.2 Market size and forecast, by By Test Type
9.4.7.1.3 Market size and forecast, by By Application
9.4.7.1.4 Market size and forecast, by By Infection Type
9.4.7.1.5 Market size and forecast, by End User
9.4.7.2 China
9.4.7.2.1 Market size and forecast, by By Product
9.4.7.2.2 Market size and forecast, by By Test Type
9.4.7.2.3 Market size and forecast, by By Application
9.4.7.2.4 Market size and forecast, by By Infection Type
9.4.7.2.5 Market size and forecast, by End User
9.4.7.3 Australia
9.4.7.3.1 Market size and forecast, by By Product
9.4.7.3.2 Market size and forecast, by By Test Type
9.4.7.3.3 Market size and forecast, by By Application
9.4.7.3.4 Market size and forecast, by By Infection Type
9.4.7.3.5 Market size and forecast, by End User
9.4.7.4 India
9.4.7.4.1 Market size and forecast, by By Product
9.4.7.4.2 Market size and forecast, by By Test Type
9.4.7.4.3 Market size and forecast, by By Application
9.4.7.4.4 Market size and forecast, by By Infection Type
9.4.7.4.5 Market size and forecast, by End User
9.4.7.5 South Korea
9.4.7.5.1 Market size and forecast, by By Product
9.4.7.5.2 Market size and forecast, by By Test Type
9.4.7.5.3 Market size and forecast, by By Application
9.4.7.5.4 Market size and forecast, by By Infection Type
9.4.7.5.5 Market size and forecast, by End User
9.4.7.6 Rest of LAMEA
9.4.7.6.1 Market size and forecast, by By Product
9.4.7.6.2 Market size and forecast, by By Test Type
9.4.7.6.3 Market size and forecast, by By Application
9.4.7.6.4 Market size and forecast, by By Infection Type
9.4.7.6.5 Market size and forecast, by End User
9.5 LAMEA
9.5.1 Key trends and opportunities
9.5.2 LAMEA Market size and forecast, by By Product
9.5.3 LAMEA Market size and forecast, by By Test Type
9.5.4 LAMEA Market size and forecast, by By Application
9.5.5 LAMEA Market size and forecast, by By Infection Type
9.5.6 LAMEA Market size and forecast, by End User
9.5.7 LAMEA Market size and forecast, by country
9.5.7.1 Brazil
9.5.7.1.1 Market size and forecast, by By Product
9.5.7.1.2 Market size and forecast, by By Test Type
9.5.7.1.3 Market size and forecast, by By Application
9.5.7.1.4 Market size and forecast, by By Infection Type
9.5.7.1.5 Market size and forecast, by End User
9.5.7.2 Saudi Arabia
9.5.7.2.1 Market size and forecast, by By Product
9.5.7.2.2 Market size and forecast, by By Test Type
9.5.7.2.3 Market size and forecast, by By Application
9.5.7.2.4 Market size and forecast, by By Infection Type
9.5.7.2.5 Market size and forecast, by End User
9.5.7.3 South Africa
9.5.7.3.1 Market size and forecast, by By Product
9.5.7.3.2 Market size and forecast, by By Test Type
9.5.7.3.3 Market size and forecast, by By Application
9.5.7.3.4 Market size and forecast, by By Infection Type
9.5.7.3.5 Market size and forecast, by End User
9.5.7.4 Rest of LAMEA
9.5.7.4.1 Market size and forecast, by By Product
9.5.7.4.2 Market size and forecast, by By Test Type
9.5.7.4.3 Market size and forecast, by By Application
9.5.7.4.4 Market size and forecast, by By Infection Type
9.5.7.4.5 Market size and forecast, by End User
LIST OF TABLES
Table 1. Global Hospital-Acquired Infection Diagnostics Market, by By Product, 2020-2030, ($Million)
Table 2. Hospital-Acquired Infection Diagnostics Market Revenue, for Instrument, by Region, 2020-2030, ($Million)
Table 3. Hospital-Acquired Infection Diagnostics Market Instrument by Country, 2020-2030, ($Million)
Table 4. Hospital-Acquired Infection Diagnostics Market Revenue, for Reagents and Consumables, by Region, 2020-2030, ($Million)
Table 5. Hospital-Acquired Infection Diagnostics Market Reagents and Consumables by Country, 2020-2030, ($Million)
Table 6. Global Hospital-Acquired Infection Diagnostics Market, by By Test Type, 2020-2030, ($Million)
Table 7. Hospital-Acquired Infection Diagnostics Market Revenue, for Molecular Diagnostics, by Region, 2020-2030, ($Million)
Table 8. Hospital-Acquired Infection Diagnostics Market Molecular Diagnostics by Country, 2020-2030, ($Million)
Table 9. Hospital-Acquired Infection Diagnostics Market Revenue, for Immunoassay, by Region, 2020-2030, ($Million)
Table 10. Hospital-Acquired Infection Diagnostics Market Immunoassay by Country, 2020-2030, ($Million)
Table 11. Hospital-Acquired Infection Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 12. Hospital-Acquired Infection Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 13. Global Hospital-Acquired Infection Diagnostics Market, by By Application, 2020-2030, ($Million)
Table 14. Hospital-Acquired Infection Diagnostics Market Revenue, for Disease Testing, by Region, 2020-2030, ($Million)
Table 15. Hospital-Acquired Infection Diagnostics Market Disease Testing by Country, 2020-2030, ($Million)
Table 16. Hospital-Acquired Infection Diagnostics Market Revenue, for Drug-Resistance Testing, by Region, 2020-2030, ($Million)
Table 17. Hospital-Acquired Infection Diagnostics Market Drug-Resistance Testing by Country, 2020-2030, ($Million)
Table 18. Global Hospital-Acquired Infection Diagnostics Market, by By Infection Type, 2020-2030, ($Million)
Table 19. Hospital-Acquired Infection Diagnostics Market Revenue, for Hospital Acquired Pneumonia, by Region, 2020-2030, ($Million)
Table 20. Hospital-Acquired Infection Diagnostics Market Hospital Acquired Pneumonia by Country, 2020-2030, ($Million)
Table 21. Hospital-Acquired Infection Diagnostics Market Revenue, for Bloodstream Infections, by Region, 2020-2030, ($Million)
Table 22. Hospital-Acquired Infection Diagnostics Market Bloodstream Infections by Country, 2020-2030, ($Million)
Table 23. Hospital-Acquired Infection Diagnostics Market Revenue, for Surgical Site Infections, by Region, 2020-2030, ($Million)
Table 24. Hospital-Acquired Infection Diagnostics Market Surgical Site Infections by Country, 2020-2030, ($Million)
Table 25. Hospital-Acquired Infection Diagnostics Market Revenue, for Gastrointestinal Infections, by Region, 2020-2030, ($Million)
Table 26. Hospital-Acquired Infection Diagnostics Market Gastrointestinal Infections by Country, 2020-2030, ($Million)
Table 27. Hospital-Acquired Infection Diagnostics Market Revenue, for Urinary Tract Infections (Uti), by Region, 2020-2030, ($Million)
Table 28. Hospital-Acquired Infection Diagnostics Market Urinary Tract Infections (Uti) by Country, 2020-2030, ($Million)
Table 29. Hospital-Acquired Infection Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 30. Hospital-Acquired Infection Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 31. Global Hospital-Acquired Infection Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 32. Hospital-Acquired Infection Diagnostics Market Revenue, for Hospital, by Region, 2020-2030, ($Million)
Table 33. Hospital-Acquired Infection Diagnostics Market Hospital by Country, 2020-2030, ($Million)
Table 34. Hospital-Acquired Infection Diagnostics Market Revenue, for Standalone Laboratories, by Region, 2020-2030, ($Million)
Table 35. Hospital-Acquired Infection Diagnostics Market Standalone Laboratories by Country, 2020-2030, ($Million)
Table 36. Hospital-Acquired Infection Diagnostics Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 37. Hospital-Acquired Infection Diagnostics Market Others by Country, 2020-2030, ($Million)
Table 38. Hospital-Acquired Infection Diagnostics Market, by Region, 2020-2030, ($Million)
Table 39. North America Hospital-Acquired Infection Diagnostics Market, by By Product, 2020-2030, ($Million)
Table 40. North America Hospital-Acquired Infection Diagnostics Market, by By Test Type, 2020-2030, ($Million)
Table 41. North America Hospital-Acquired Infection Diagnostics Market, by By Application, 2020-2030, ($Million)
Table 42. North America Hospital-Acquired Infection Diagnostics Market, by By Infection Type, 2020-2030, ($Million)
Table 43. North America Hospital-Acquired Infection Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 44. North America Hospital-Acquired Infection Diagnostics Market, by Country, 2020-2030, ($Million)
Table 45. U.S. Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 46. U.S. Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 47. U.S. Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 48. U.S. Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 49. U.S. Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 50. Canada Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 51. Canada Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 52. Canada Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 53. Canada Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 54. Canada Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 55. Mexico Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 56. Mexico Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 57. Mexico Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 58. Mexico Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 59. Mexico Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 60. Europe Hospital-Acquired Infection Diagnostics Market, by By Product, 2020-2030, ($Million)
Table 61. Europe Hospital-Acquired Infection Diagnostics Market, by By Test Type, 2020-2030, ($Million)
Table 62. Europe Hospital-Acquired Infection Diagnostics Market, by By Application, 2020-2030, ($Million)
Table 63. Europe Hospital-Acquired Infection Diagnostics Market, by By Infection Type, 2020-2030, ($Million)
Table 64. Europe Hospital-Acquired Infection Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 65. Europe Hospital-Acquired Infection Diagnostics Market, by Country, 2020-2030, ($Million)
Table 66. Germany Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 67. Germany Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 68. Germany Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 69. Germany Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 70. Germany Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 71. France Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 72. France Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 73. France Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 74. France Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 75. France Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 76. U.K. Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 77. U.K. Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 78. U.K. Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 79. U.K. Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 80. U.K. Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 81. Italy Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 82. Italy Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 83. Italy Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 84. Italy Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 85. Italy Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 86. Spain Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 87. Spain Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 88. Spain Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 89. Spain Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 90. Spain Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 91. Rest of Europe Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 92. Rest of Europe Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 93. Rest of Europe Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 94. Rest of Europe Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 95. Rest of Europe Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 96. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by By Product, 2020-2030, ($Million)
Table 97. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by By Test Type, 2020-2030, ($Million)
Table 98. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by By Application, 2020-2030, ($Million)
Table 99. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by By Infection Type, 2020-2030, ($Million)
Table 100. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 101. Asia-Pacific Hospital-Acquired Infection Diagnostics Market, by Country, 2020-2030, ($Million)
Table 102. Japan Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 103. Japan Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 104. Japan Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 105. Japan Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 106. Japan Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 107. China Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 108. China Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 109. China Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 110. China Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 111. China Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 112. Australia Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 113. Australia Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 114. Australia Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 115. Australia Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 116. Australia Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 117. India Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 118. India Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 119. India Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 120. India Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 121. India Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 122. South Korea Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 123. South Korea Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 124. South Korea Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 125. South Korea Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 126. South Korea Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 127. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 128. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 129. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 130. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 131. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 132. LAMEA Hospital-Acquired Infection Diagnostics Market, by By Product, 2020-2030, ($Million)
Table 133. LAMEA Hospital-Acquired Infection Diagnostics Market, by By Test Type, 2020-2030, ($Million)
Table 134. LAMEA Hospital-Acquired Infection Diagnostics Market, by By Application, 2020-2030, ($Million)
Table 135. LAMEA Hospital-Acquired Infection Diagnostics Market, by By Infection Type, 2020-2030, ($Million)
Table 136. LAMEA Hospital-Acquired Infection Diagnostics Market, by End-user, 2020-2030, ($Million)
Table 137. LAMEA Hospital-Acquired Infection Diagnostics Market, by Country, 2020-2030, ($Million)
Table 138. Brazil Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 139. Brazil Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 140. Brazil Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 141. Brazil Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 142. Brazil Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 143. Saudi Arabia Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 144. Saudi Arabia Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 145. Saudi Arabia Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 146. Saudi Arabia Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 147. Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 148. South Africa Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 149. South Africa Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 150. South Africa Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 151. South Africa Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 152. South Africa Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 153. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Product 2020-2030, ($Million)
Table 154. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Test Type 2020-2030, ($Million)
Table 155. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Application 2020-2030, ($Million)
Table 156. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by By Infection Type 2020-2030, ($Million)
Table 157. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End-user 2020-2030, ($Million)
Table 158. Abbott Laboratories: Company Snapshot
Table 159. Abbott Laboratories: Operating Segments
Table 160. Abbott Laboratories: Product Portfolio
Table 161. Abbott Laboratories: Net Sales
Table 162. Abbott Laboratories: Key Stratergies
Table 163. Ecolab: Company Snapshot
Table 164. Ecolab: Operating Segments
Table 165. Ecolab: Product Portfolio
Table 166. Ecolab: Net Sales
Table 167. Ecolab: Key Stratergies
Table 168. Johnson & Johnson: Company Snapshot
Table 169. Johnson & Johnson: Operating Segments
Table 170. Johnson & Johnson: Product Portfolio
Table 171. Johnson & Johnson: Net Sales
Table 172. Johnson & Johnson: Key Stratergies
Table 173. Merck KGaA: Company Snapshot
Table 174. Merck KGaA: Operating Segments
Table 175. Merck KGaA: Product Portfolio
Table 176. Merck KGaA: Net Sales
Table 177. Merck KGaA: Key Stratergies
Table 178. Bayer Schering Pharma LLC: Company Snapshot
Table 179. Bayer Schering Pharma LLC: Operating Segments
Table 180. Bayer Schering Pharma LLC: Product Portfolio
Table 181. Bayer Schering Pharma LLC: Net Sales
Table 182. Bayer Schering Pharma LLC: Key Stratergies
Table 183. Becton Dickinson and Company: Company Snapshot
Table 184. Becton Dickinson and Company: Operating Segments
Table 185. Becton Dickinson and Company: Product Portfolio
Table 186. Becton Dickinson and Company: Net Sales
Table 187. Becton Dickinson and Company: Key Stratergies
Table 188. Pfizer Inc.: Company Snapshot
Table 189. Pfizer Inc.: Operating Segments
Table 190. Pfizer Inc.: Product Portfolio
Table 191. Pfizer Inc.: Net Sales
Table 192. Pfizer Inc.: Key Stratergies
Table 193. Steris plc: Company Snapshot
Table 194. Steris plc: Operating Segments
Table 195. Steris plc: Product Portfolio
Table 196. Steris plc: Net Sales
Table 197. Steris plc: Key Stratergies
Table 198. Hologic, Inc.: Company Snapshot
Table 199. Hologic, Inc.: Operating Segments
Table 200. Hologic, Inc.: Product Portfolio
Table 201. Hologic, Inc.: Net Sales
Table 202. Hologic, Inc.: Key Stratergies
Table 203. Danaher Corporation: Company Snapshot
Table 204. Danaher Corporation: Operating Segments
Table 205. Danaher Corporation: Product Portfolio
Table 206. Danaher Corporation: Net Sales
Table 207. Danaher Corporation: Key Stratergies
LIST OF FIGURES
Figure 1. Hospital-Acquired Infection Diagnostics Market Segmentation
Figure 2. Hospital-Acquired Infection Diagnostics Market, 2020-2030
Figure 3. Hospital-Acquired Infection Diagnostics Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Hospital-Acquired Infection Diagnostics Market:Drivers, Restraints and Opportunities
Figure 12. Hospital-Acquired Infection Diagnostics Market, by by Product, 2020 (%)
Figure 13. Comparative Share Analysis of Instrument Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of Reagents and Consumables Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 15. Hospital-Acquired Infection Diagnostics Market, by by Test Type, 2020 (%)
Figure 16. Comparative Share Analysis of Molecular Diagnostics Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Immunoassay Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Others Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 19. Hospital-Acquired Infection Diagnostics Market, by by Application, 2020 (%)
Figure 20. Comparative Share Analysis of Disease Testing Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 21. Comparative Share Analysis of Drug-Resistance Testing Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 22. Hospital-Acquired Infection Diagnostics Market, by by Infection Type, 2020 (%)
Figure 23. Comparative Share Analysis of Hospital Acquired Pneumonia Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 24. Comparative Share Analysis of Bloodstream Infections Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 25. Comparative Share Analysis of Surgical Site Infections Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 26. Comparative Share Analysis of Gastrointestinal Infections Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 27. Comparative Share Analysis of Urinary Tract Infections (Uti) Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 28. Comparative Share Analysis of Others Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 29. Hospital-Acquired Infection Diagnostics Market, by End-user, 2020 (%)
Figure 30. Comparative Share Analysis of Hospital Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 31. Comparative Share Analysis of Standalone Laboratories Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 32. Comparative Share Analysis of Others Hospital-Acquired Infection Diagnostics Market, 2020-2030 (%)
Figure 33. Hospital-Acquired Infection Diagnostics Market by Region, 2020
Figure 34. U.S. Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 35. Canada Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 36. Mexico Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 37. Germany Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 38. France Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 39. U.K. Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 40. Italy Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 41. Spain Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 42. Rest of Europe Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 43. Japan Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 44. China Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 45. Australia Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 46. India Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 47. South Korea Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 48. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 49. Brazil Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 50. Saudi Arabia Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 51. South Africa Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 52. Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2020-2030 ($Million)
Figure 53. Top Winning Strategies, by Year
Figure 54. Top Winning Strategies, by Development
Figure 55. Top Winning Strategies, by Company
Figure 56. Product Mapping of Top 10 Players
Figure 57. Competitive Dashboard
Figure 58. Competitive Heatmap of Top 10 Key Players
Figure 59. Abbott Laboratories.: Net Sales, ($Million)
Figure 60. Ecolab.: Net Sales, ($Million)
Figure 61. Johnson & Johnson.: Net Sales, ($Million)
Figure 62. Merck KGaA.: Net Sales, ($Million)
Figure 63. Bayer Schering Pharma LLC.: Net Sales, ($Million)
Figure 64. Becton Dickinson and Company.: Net Sales, ($Million)
Figure 65. Pfizer Inc. Net Sales, ($Million)
Figure 66. Steris PLC.: Net Sales, ($Million)
Figure 67. Hologic, Inc. Net Sales, ($Million)
Figure 68. Danaher Corporation.: Net Sales, ($Million)
